Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of PI3K/AKT/mTOR Signaling Pathway Using BKM120 in Early Breast Cancer

NCT01513356 is registered in ClinicalTrials.gov with Sofia Perea, Director Clinical Trials Unit. as lead sponsor.

NCT NCT01513356
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01513356 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of PI3K/AKT/mTOR Signaling Pathway Using BKM120 in Early Breast Cancer
Lead sponsor
Sofia Perea, Director Clinical Trials Unit.
Phase
Phase 1
Overall status
Completed
Start date
October 31, 2012
Completion date
February 28, 2014
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer